SPONSOR
Perspective Therapeutics
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Pancreatic Ductal AdenocarcinomaGastric CancerEsophageal CancerColorectal CancerOvarian CancerHead and Neck CancerSarcomaMesotheliomaNeuroendocrine Tumors UnresectableNeuroendocrine Tumor Metastatic
NCT06710756 Phase 1, Phase 2
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Pancreatic Ductal Adenocarcinoma
NCT05636618 Phase 1, Phase 2
Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors
Neuroendocrine Tumors Unresectable